Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001179110-22-002909

Director acquired 6,206 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Henderson Jeffrey William · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2022-05-05 Grant or award : show line 1 in the form +6,206 59,045 D
Loading xslF345X03/edgar.xml…